Alloy operates a telehealth platform that links women with physicians trained in menopause care, offering clinician community support and annual in-person training for its providers. The company emphasizes capital-efficient growth, claiming near-zero physician attrition and zero recruiting costs because clinicians join organically. Alloy reached profitability around its Series A in November 2024 and has since reinvested earnings into growth rather than hoarding cash. Its leadership, including co‑founders and co‑CEOs Anne Fulenwider and Monica Molenaar, positions the company as deliberately disciplined compared with better‑funded peers. The broader market context cited in reporting notes roughly 1.3 million U.S. women enter menopause each year and a global menopause market valued at about $17.8 billion in 2024. Alloy is pursuing a retention- and unit-economics-driven expansion rather than rapid, capital-intensive scaling.

Total raised

$19M

Funding rounds

2

Latest round

Equity

Latest activity

Jun 2026